Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,167 | -61,319 | -111,637 | -30,602 | -109,006 |
| Depreciation Amortization | 3,882 | 7,740 | 8,649 | 10,184 | 9,813 |
| Accounts receivable | 672 | -181 | -232 | 9,512 | -9,035 |
| Accounts payable and accrued liabilities | -2,096 | 1,508 | 153 | 867 | -1,455 |
| Other Working Capital | -55,989 | -41,487 | 24,110 | 19,584 | -2,014 |
| Other Operating Activity | -12,081 | 9,625 | 33,204 | -20,398 | 24,311 |
| Operating Cash Flow | $-58,445 | $-84,114 | $-45,753 | $-10,853 | $-87,386 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -190 | -1,850 | -3,319 | -5,053 | -5,031 |
| Net Acquisitions | N/A | 8,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -25 | -321 | N/A | -750 | N/A |
| Other Investing Activity | -25 | -321 | 0 | -750 | 0 |
| Investing Cash Flow | $-215 | $5,829 | $-3,319 | $-5,803 | $-5,031 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 22,468 | N/A | 19,805 | 4,970 | N/A |
| Debt Repayment | N/A | N/A | N/A | -2,513 | N/A |
| Common Stock Issued | 50,487 | 5,387 | 75,180 | 68,064 | 1,329 |
| Other Financing Activity | -22,505 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $50,450 | $5,387 | $94,985 | $70,521 | $1,329 |
| Beginning Cash Position | 116,678 | 189,576 | 143,663 | 89,798 | 180,886 |
| End Cash Position | 108,468 | 116,678 | 189,576 | 143,663 | 89,798 |
| Net Cash Flow | $-8,210 | $-72,898 | $45,913 | $53,865 | $-91,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,445 | -84,114 | -45,753 | -10,853 | -87,386 |
| Capital Expenditure | -250 | -1,957 | -3,319 | -5,053 | -5,031 |
| Free Cash Flow | -58,695 | -86,071 | -49,072 | -15,906 | -92,417 |